The global antihistamine product market was valued at US$ 263.9 billion in 2022. The market is expected to expand at a CAGR of 8.6% and reach a valuation of ~US$ 647.7 billion by 2033.
| Data Points | Market Insights |
|---|---|
| Antihistamine Market Value, 2022 | US$ 263.9 billion |
| Antihistamine Market Value, 2023 | US$ 284.2 billion |
| Antihistamine Market Value, 2033 | US$ 647.7 billion |
| CAGR (2023 to 2033) | 8.6% |
| Market Share of Top 5 Countries | 50.5% |
| Key Market Players | GlaxoSmithKline PLC., Sanofi Consumer Healthcare, Himalaya Wellness Company, Sun Pharmaceutical Industries, Inc., Bayer AG, Novartis AG, Cadila Pharmaceuticals, Bausch Health Companies Inc., Alcon Vision LLC., Merck & Co., Dr. Reddy’s Laboratories, Ltd., Viatris Inc., Somerset Pharma, LLC, F. Hoffmann- La Roche Ltd., Akorn Operating Company LLC, Teva Pharmaceutical Industries Ltd., Speer laboratories, Glenmark Pharmaceuticals Limited, TerSera Therapeutics LLC, Pfizer Inc., Morepen Laboratories Limited, Johnson & Johnson Sevices Inc., Pharmaceutical Specialties Inc., Proctor & Gamble |
The antihistamine market has observed significant growth over the last decade. The increasing prevalence of allergies and allergic reactions across the globe has expanded the growth of the antihistamine market. Antihistamine drugs are used to treat a variety of allergies and allergic reactions, as it is an anti-allergic medication. The body acts on certain histamine receptors and releases histamine throughout an allergic reaction. Antihistamine can also treat pruritus-related conditions such as atopic dermatitis, insect bites, and other conditions. Moreover, H-1 and H-2 types of antihistamine are used to treat other conditions such as insomnia, motion sickness, anxiety and heartburn, gastric ulcers, and others, respectively.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market value for antihistamines was approximately 1.3% of the overall global allergy treatment market worth ~US$ 19,070.0 billion in 2022.
| Historical Antihistamine Market Value (2022) | US$ 263.9 billion |
|---|---|
| Historical CAGR (2017 to 2022) | 5.9% |
The sale of antihistamines expanded at a CAGR of 5.9% from 2017 to 2022. The demand for antihistamine products will keep up strong in the years ahead. The preference for antihistamine drugs for treatment procedures is growing as the accessibility of these drugs is highly convenient through retail pharmacies, hospital pharmacies, and online pharmacies. This is one of the factors influencing the production growth of antihistamines. Numerous manufacturers are utilizing different antihistamine dosage forms to enhance their market share.
Allergic reactions caused on the skin are distinguished by red, peeling, dry, swollen surface, itch, and rash. The most common triggering factor for allergies is the overreaction of histamine in the body; this is when antihistamines come into action. Antihistamines assist in reducing inflammation, which usually alleviates the pain. Apart from that, skin conditions such as allergic rhinitis can occur due to prolonged and repeated exposure to dust mites, molds, or pet dander. It can further lead to symptoms such as nasal congestion and irritation in the nose, throat, and eyes, increasing the growth of the antihistamine market.
Medical professionals prescribe antihistamines to relieve symptoms of insomnia as well. Due to the current environment and lifestyle, such as unstable working shifts, smoking, varied sleeping patterns and others, the antihistamine market has witnessed growth in conditions such as insomnia, which is the most common issue among the general population today. According to an article published by the American Journal of Managed Care in 2020, around 30% to 40% of the U.S adult population develop symptoms of insomnia per year. The inability to fall asleep or stay asleep can have a major influence on productivity and mood. It can be a symptom or a cause of other underlying medical disorders. Easily available over-the-counter drugs such as diphenhydramine can assist in sleeping aids. An antihistamine is not a first-line treatment for insomnia but first-generation antihistamine blocks H-1 histamine receptors, which can cause sedation and make the patients drowsy. These factors can be favorable for the antihistamine market.
Thus, owing to the aforementioned factors, the global market is expected to grow at a CAGR of 8.6% during the forecast period from 2023 to 2033.
The growth will be driven by the increasing concerns regarding the prevalence of allergic reactions and other conditions such as urticaria and anxiety across the globe. Further, the market opportunistic outlook is owing to the increasing investments in research and development, due to which drug approvals are rising and new products concerning antihistamine drugs are being launched, which is expanding the market. For instance, in May 2022, Glenmark Pharmaceuticals launched a nasal spray in India named Ryaltris-AZ. Ryaltris-AZ was introduced as the first-line treatment for allergic rhinitis with a mixture of intranasal antihistamines and corticosteroids.
Moreover, a number of manufacturers are expanding their line of medications by providing antihistamine drugs in multiple routes of administration, increasing the range of antihistamine-related products in the market. Hence, in the forthcoming years, the antihistamine market is expected to dispense lucrative growth opportunities.
Principal Consultant
Sometimes, due to a lack of awareness among the rural population in some developing countries, it becomes difficult to cope with allergies and other conditions. It is because of negligence and inability to seek medical help. This is a crucial factor hampering the growth of the market.
Antihistamine blocks the process of histamine, but at times, there are a few side effects that can be caused due to antihistamines. These side effects include drowsiness, dry mouth, dry eyes, sore throat, and others. This factor acts as a barrier and affects the growth of the market in a negative manner.
| Countries | CAGR (2023 to 2033) |
|---|---|
| United States | 8.9% |
| China | 8.6% |
| United Kingdom | 8.0% |
| Germany | 8.2% |
| India | 7.8% |
The United States dominates the North American region, with a total market share of about 85.4% in 2022. The market is expected to grow at a CAGR of 8.9% through 2033.
According to the Centers for Disease Control and Prevention, more than 60 million people per year in the United States suffer from hay fever. It was also reported that seven out of ten patients in 2020 were suffering from hay fever along with allergic conjunctivitis that causes red, watery, and itchy eyes. The prevalence of allergies in the U.S. is driving the market. There are numerous antihistamine medications that provide relief from such inflammation symptoms. These are the prime drivers for the market within the country.
China dominates the East Asian region with a total market share of about 51.2%. It is estimated to grow at a CAGR of 8.6% throughout the forecast period.
Allergic rhinitis is becoming a major concern in terms of health and economy in China. Children in China are more prone to such disorders due to allergens like house dust mites. As the prevalence of allergies and allergic reactions is rising, the demand for antihistamines is increasing, boosting market growth.
India is set to exhibit a CAGR growth rate of nearly 7.8% during the forecast period. Due to the increasing prevalence of allergic conjunctivitis in the general population of India, the consumption of the antihistamines for the treatment is increasing, contributing to the growth of the Indian market.
Allergy-based disorders in India are becoming a matter of concern due to factors like the illiteracy among the rural population and paucity of allergy specialists.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Top Product | H-1 blockers |
|---|---|
| CAGR (2023 to 2033) | 8.9% |
H-1 blockers are expected to present high growth at a CAGR of 8.9% over the forecast period, with a market share of about 55.9%. H-1 antihistamines can alleviate the pain caused by allergic conjunctivitis, skin rashes and hypersensitivity toward certain drugs.
| Top Type | Over-the-counter |
|---|---|
| CAGR (2023 to 2033) | 9.0% |
Over-the-counter antihistamines are dominating the market with a share of 51.3% in 2022. This segment is expected to present high growth at a CAGR of 9.0% by the end of the forecast period. Antihistamine drugs are easily available through over-the-counter means. Therefore, this segment is considered to be dominant in the type category.
| Top Dosage | Tablets |
|---|---|
| CAGR (2023 to 2033) | 9.7% |
Tablets hold a market share of 35.0% in 2022 and are expected to display gradual growth over the forecast period, with a CAGR of 9.7%. Tablets are one the most convenient and economical dosage forms of antihistamines.
| Top Route of Administration | Oral |
|---|---|
| CAGR (2023 to 2033) | 8.0% |
The oral route of administration is dominating the market and is expected to grow at a CAGR of 8.0% over the forecast period, with a market share of about 48.7% in the global market in 2031. Oral medications are quite advantageous as compared to parental and topical medications. These advantages include patient preference, the convenience of drug administration, and cost-effectiveness.
| Top Distribution Channel | Hospital pharmacies |
|---|---|
| CAGR (2023 to 2033) | 9.1% |
Hospital pharmacies hold a prominent market share value of 42.9% during the year 2022 with a CAGR of 9.1%. The increasing number of hospital pharmacies is a factor contributing to the prominent share of hospital pharmacies in the distribution channel category.
The market is a highly fragmented market with numerous key players. To meet consumer demands and strengthen their presence worldwide, these companies are executing a new range of products and regulatory approvals. Few of the key developmental strategies of market players are given below:
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | US$ billion for Value |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Germany, France, Italy, UK, Spain, Russia BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, China, Japan, South Korea, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa |
| Key Market Segments Covered | Product, Type, Dosage Forms, Route of Administration, Indication, Distribution Channel and Region |
| Key Companies Profiled |
|
| Pricing | Available upon Request |
The global antihistamine market is worth US$ 263.9 billion in 2022.
The antihistamine market is expected to reach US$ 647.7 billion by 2033, growing at a CAGR of 8.6% over the forecast period.
Increased efficacy of antihistamines with respect to relieving symptoms and allergic reactions across the globe.
North America dominated the global antihistamine market accounting for a prominent market share of 34.6%.
The market in India is likely to grow with a CAGR of 7.8% over the forecast period.
The United States, China, the United Kingdom, Germany, and India are the top five countries, which are expected to drive demand for antihistamines.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Value Added Insights 4.1. Product Adoption / Usage Analysis 4.2. Product USPs / Features 4.3. PESTLE Analysis 4.4. Porter Analysis 4.5. Regulatory Scenario 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP Growth Outlook 5.1.2. Global Healthcare Expenditure Outlook 5.1.3. Global Allergy Treatment Market Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Historic Growth of the Top Companies 5.2.2. Rising Prevalence of Allergies and Allergic Reactions 5.2.3. Mergers and Acquisitions 5.2.4. Strategic Collaborations 5.2.5. Adoption Rate 5.2.6. Product and Stock Availability 5.3. Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Demand (in Value or Size in US$ Billion) Analysis 2017 to 2022 and Forecast, 2023 to 2033 6.1. Historical Market Value (US$ Billion) Analysis, 2017 to 2022 6.2. Current and Future Market Value (US$ Billion) Projections, 2023 to 2033 6.2.1. Y-o-Y Growth Trend Analysis 6.2.2. Absolute $ Opportunity Analysis 7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Product 7.1. Introduction / Key Findings 7.2. Historical Market Size (US$ Billion) Analysis By Product, 2017 to 2022 7.3. Current and Future Market Size (US$ Billion) and Analysis and Forecast By Product, 2023 to 2033 7.3.1. H-1 Blockers 7.3.2. H-2 Blockers 7.4. Market Attractiveness Analysis By Product 8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Type 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Billion) Analysis By Type, 2017 to 2022 8.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Type, 2023 to 2033 8.3.1. Prescription-based 8.3.2. Over-the-counter 8.4. Market Attractiveness Analysis By Type 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Dosage Forms 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Billion) Analysis By Dosage Forms, 2017 to 2022 9.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Dosage Forms, 2023 to 2033 9.3.1. Tablets 9.3.2. Capsules 9.3.3. Liquids 9.3.4. Other 9.4. Market Attractiveness Analysis By Dosage Forms 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Route of Administration 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Billion) Analysis By Route of Administration, 2017 to 2022 10.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Route of Administration, 2023 to 2033 10.3.1. Oral 10.3.2. Parenteral 10.3.3. Topical 10.4. Market Attractiveness Analysis By Route of Administration 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Indication 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Billion) Analysis By Indication, 2017 to 2022 11.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Indication, 2023 to 2033 11.3.1. Allergies 11.3.2. Urticaria 11.3.3. Dermatitis 11.3.4. Others 11.4. Market Attractiveness Analysis By Indication 12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Distribution Channel 12.1. Introduction / Key Findings 12.2. Historical Market Size (US$ Billion) Analysis By Distribution Channel, 2017 to 2022 12.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Distribution Channel, 2023 to 2033 12.3.1. Hospital Pharmacies 12.3.2. Retail Pharmacies 12.3.3. Drug Stores 12.3.4. Online Pharmacies 12.4. Market Attractiveness Analysis By Distribution Channel 13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region 13.1. Introduction 13.2. Historical Market Size (US$ Billion) Analysis By Region, 2017 to 2022 13.3. Current Market Size (US$ Billion) Analysis and Forecast By Region, 2023 to 2033 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. South Asia 13.3.5. East Asia 13.3.6. Oceania 13.3.7. Middle East and Africa (MEA) 13.4. Market Attractiveness Analysis By Region 14. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Historical Market Size (US$ Billion) Analysis By Market Taxonomy, 2017 to 2022 14.3. Market Size (US$ Billion) Forecast By Market Taxonomy, 2023 to 2033 14.3.1. By Country 14.3.1.1. USA 14.3.1.2. Canada 14.3.2. By Product 14.3.3. By Type 14.3.4. By Dosage Forms 14.3.5. By Route of Administration 14.3.6. By Indication 14.3.7. By Distribution Channel 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By Type 14.4.4. By Dosage Forms 14.4.5. By Route of Administration 14.4.6. By Indication 14.4.7. By Distribution Channel 14.5. Country Level Analysis & Forecast 14.5.1. USA Market Analysis 14.5.1.1. Introduction 14.5.1.2. Market Analysis and Forecast by Market Taxonomy 14.5.1.2.1. By Product 14.5.1.2.2. By Type 14.5.1.2.3. By Dosage Forms 14.5.1.2.4. By Route of Administration 14.5.1.2.5. By Indication 14.5.1.2.6. By Distribution Channel 14.5.2. Canada Market Analysis 14.5.2.1. Introduction 14.5.2.2. Market Analysis and Forecast by Market Taxonomy 14.5.2.2.1. By Product 14.5.2.2.2. By Type 14.5.2.2.3. By Dosage Forms 14.5.2.2.4. By Route of Administration 14.5.2.2.5. By Indication 14.5.2.2.6. By Distribution Channel 14.6. Market Trends 14.7. Key Market Participants - Intensity Mapping 14.8. Drivers and Restraints - Impact Analysis 15. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Historical Market Size (US$ Billion) Analysis By Market Taxonomy, 2017 to 2022 15.3. Market Size (US$ Billion) Forecast By Market Taxonomy, 2023 to 2033 15.3.1. By Country 15.3.1.1. Brazil 15.3.1.2. Mexico 15.3.1.3. Argentina 15.3.1.4. Rest of Latin America 15.3.2. By Product 15.3.3. By Type 15.3.4. By Dosage Forms 15.3.5. By Route of Administration 15.3.6. By Indication 15.3.7. By Distribution Channel 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Type 15.4.4. By Dosage Forms 15.4.5. By Route of Administration 15.4.6. By Indication 15.4.7. By Distribution Channel 15.5. Country Level Analysis & Forecast 15.5.1. Brazil Market Analysis 15.5.1.1. Introduction 15.5.1.2. Market Analysis and Forecast by Market Taxonomy 15.5.1.2.1. By Product 15.5.1.2.2. By Type 15.5.1.2.3. By Dosage Forms 15.5.1.2.4. By Route of Administration 15.5.1.2.5. By Indication 15.5.1.2.6. By Distribution Channel 15.5.2. Mexico Market Analysis 15.5.2.1. Introduction 15.5.2.2. Market Analysis and Forecast by Market Taxonomy 15.5.2.2.1. By Product 15.5.2.2.2. By Type 15.5.2.2.3. By Dosage Forms 15.5.2.2.4. By Route of Administration 15.5.2.2.5. By Indication 15.5.2.2.6. By Distribution Channel 15.5.3. Argentina Market Analysis 15.5.3.1. Introduction 15.5.3.2. Market Analysis and Forecast by Market Taxonomy 15.5.3.2.1. By Product 15.5.3.2.2. By Type 15.5.3.2.3. By Dosage Forms 15.5.3.2.4. By Route of Administration 15.5.3.2.5. By Indication 15.5.3.2.6. By Distribution Channel 15.6. Market Trends 15.7. Key Market Participants - Intensity Mapping 15.8. Drivers and Restraints - Impact Analysis 16. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.2. Historical Market Size (US$ Billion) Analysis By Market Taxonomy, 2017 to 2022 16.3. Market Size (US$ Billion) Forecast, By Market Taxonomy, 2023 to 2033 16.3.1. By Country 16.3.1.1. Germany 16.3.1.2. France 16.3.1.3. Italy 16.3.1.4. UK 16.3.1.5. Spain 16.3.1.6. Russia 16.3.1.7. BENELUX 16.3.1.8. Nordic Countries 16.3.1.9. Rest of Europe 16.3.2. By Product 16.3.3. By Type 16.3.4. By Dosage Forms 16.3.5. By Route of Administration 16.3.6. By Indication 16.3.7. By Distribution Channel 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Type 16.4.4. By Dosage Forms 16.4.5. By Route of Administration 16.4.6. By Indication 16.4.7. By Distribution Channel 16.5. Country Level Analysis & Forecast 16.5.1. Germany Market Analysis 16.5.1.1. Introduction 16.5.1.2. Market Analysis and Forecast by Market Taxonomy 16.5.1.2.1. By Product 16.5.1.2.2. By Type 16.5.1.2.3. By Dosage Forms 16.5.1.2.4. By Route of Administration 16.5.1.2.5. By Indication 16.5.1.2.6. By Distribution Channel 16.5.2. France Market Analysis 16.5.2.1. Introduction 16.5.2.2. Market Analysis and Forecast by Market Taxonomy 16.5.2.2.1. By Product 16.5.2.2.2. By Type 16.5.2.2.3. By Dosage Forms 16.5.2.2.4. By Route of Administration 16.5.2.2.5. By Indication 16.5.2.2.6. By Distribution Channel 16.5.3. Italy Market Analysis 16.5.3.1. Introduction 16.5.3.2. Market Analysis and Forecast by Market Taxonomy 16.5.3.2.1. By Product 16.5.3.2.2. By Type 16.5.3.2.3. By Dosage Forms 16.5.3.2.4. By Route of Administration 16.5.3.2.5. By Indication 16.5.3.2.6. By Distribution Channel 16.5.4. UK Market Analysis 16.5.4.1. Introduction 16.5.4.2. Market Analysis and Forecast by Market Taxonomy 16.5.4.2.1. By Product 16.5.4.2.2. By Type 16.5.4.2.3. By Dosage Forms 16.5.4.2.4. By Route of Administration 16.5.4.2.5. By Indication 16.5.4.2.6. By Distribution Channel 16.5.5. Spain Market Analysis 16.5.5.1. Introduction 16.5.5.2. Market Analysis and Forecast by Market Taxonomy 16.5.5.2.1. By Product 16.5.5.2.2. By Type 16.5.5.2.3. By Dosage Forms 16.5.5.2.4. By Route of Administration 16.5.5.2.5. By Indication 16.5.5.2.6. By Distribution Channel 16.5.6. Russia Market Analysis 16.5.6.1. Introduction 16.5.6.2. Market Analysis and Forecast by Market Taxonomy 16.5.6.2.1. By Product 16.5.6.2.2. By Type 16.5.6.2.3. By Dosage Forms 16.5.6.2.4. By Route of Administration 16.5.6.2.5. By Indication 16.5.6.2.6. By Distribution Channel 16.5.7. Nordic Countries Market Analysis 16.5.7.1. Introduction 16.5.7.2. Market Analysis and Forecast by Market Taxonomy 16.5.7.2.1. By Product 16.5.7.2.2. By Type 16.5.7.2.3. By Dosage Forms 16.5.7.2.4. By Route of Administration 16.5.7.2.5. By Indication 16.5.7.2.6. By Distribution Channel 16.5.8. BENELUX Market Analysis 16.5.8.1. Introduction 16.5.8.2. Market Analysis and Forecast by Market Taxonomy 16.5.8.2.1. By Product 16.5.8.2.2. By Type 16.5.8.2.3. By Dosage Forms 16.5.8.2.4. By Route of Administration 16.5.8.2.5. By Indication 16.5.8.2.6. By Distribution Channel 16.6. Market Trends 16.7. Key Market Participants - Intensity Mapping 16.8. Drivers and Restraints - Impact Analysis 17. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17.1. Introduction 17.2. Historical Market Size (US$ Billion) Analysis By Market Taxonomy, 2017 to 2022 17.3. Market Size (US$ Billion) Forecast By Market Taxonomy, 2023 to 2033 17.3.1. By Country 17.3.1.1. India 17.3.1.2. Thailand 17.3.1.3. Indonesia 17.3.1.4. Malaysia 17.3.1.5. Rest of South Asia 17.3.2. By Product 17.3.3. By Type 17.3.4. By Dosage Forms 17.3.5. By Route of Administration 17.3.6. By Indication 17.3.7. By Distribution Channel 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Type 17.4.4. By Dosage Forms 17.4.5. By Route of Administration 17.4.6. By Indication 17.4.7. By Distribution Channel 17.5. Country Level Analysis & Forecast 17.5.1. India Market Analysis 17.5.1.1. Introduction 17.5.1.2. Market Analysis and Forecast by Market Taxonomy 17.5.1.2.1. By Product 17.5.1.2.2. By Type 17.5.1.2.3. By Dosage Forms 17.5.1.2.4. By Route of Administration 17.5.1.2.5. By Indication 17.5.1.2.6. By Distribution Channel 17.5.2. Thailand Market Analysis 17.5.2.1. Introduction 17.5.2.2. Market Analysis and Forecast by Market Taxonomy 17.5.2.2.1. By Product 17.5.2.2.2. By Type 17.5.2.2.3. By Dosage Forms 17.5.2.2.4. By Route of Administration 17.5.2.2.5. By Indication 17.5.2.2.6. By Distribution Channel 17.5.3. Indonesia Market Analysis 17.5.3.1. Introduction 17.5.3.2. Market Analysis and Forecast by Market Taxonomy 17.5.3.2.1. By Product 17.5.3.2.2. By Type 17.5.3.2.3. By Dosage Forms 17.5.3.2.4. By Route of Administration 17.5.3.2.5. By Indication 17.5.3.2.6. By Distribution Channel 17.5.4. Malaysia Market Analysis 17.5.4.1. Introduction 17.5.4.2. Market Analysis and Forecast by Market Taxonomy 17.5.4.2.1. By Product 17.5.4.2.2. By Type 17.5.4.2.3. By Dosage Forms 17.5.4.2.4. By Route of Administration 17.5.4.2.5. By Indication 17.5.4.2.6. By Distribution Channel 17.6. Market Trends 17.7. Key Market Participants - Intensity Mapping 17.8. Drivers and Restraints - Impact Analysis 18. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18.1. Introduction 18.2. Historical Market Size (US$ Billion) Analysis By Market Taxonomy, 2017 to 2022 18.3. Market Size (US$ Billion) Forecast By Market Taxonomy, 2023 to 2033 18.3.1. By Country 18.3.1.1. China 18.3.1.2. Japan 18.3.1.3. South Korea 18.3.2. By Product 18.3.3. By Type 18.3.4. By Dosage Forms 18.3.5. By Route of Administration 18.3.6. By Indication 18.3.7. By Distribution Channel 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By Type 18.4.4. By Dosage Forms 18.4.5. By Route of Administration 18.4.6. By Indication 18.4.7. By Distribution Channel 18.5. Country Level Analysis & Forecast 18.5.1. China Market Analysis 18.5.1.1. Introduction 18.5.1.2. Market Analysis and Forecast by Market Taxonomy 18.5.1.2.1. By Product 18.5.1.2.2. By Type 18.5.1.2.3. By Dosage Forms 18.5.1.2.4. By Route of Administration 18.5.1.2.5. By Indication 18.5.1.2.6. By Distribution Channel 18.5.2. Japan Market Analysis 18.5.2.1. Introduction 18.5.2.2. Market Analysis and Forecast by Market Taxonomy 18.5.2.2.1. By Product 18.5.2.2.2. By Type 18.5.2.2.3. By Dosage Forms 18.5.2.2.4. By Route of Administration 18.5.2.2.5. By Indication 18.5.2.2.6. By Distribution Channel 18.5.3. South Korea Market Analysis 18.5.3.1. Introduction 18.5.3.2. Market Analysis and Forecast by Market Taxonomy 18.5.3.2.1. By Product 18.5.3.2.2. By Type 18.5.3.2.3. By Dosage Forms 18.5.3.2.4. By Route of Administration 18.5.3.2.5. By Indication 18.5.3.2.6. By Distribution Channel 18.6. Market Trends 18.7. Key Market Participants - Intensity Mapping 18.8. Drivers and Restraints - Impact Analysis 19. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 19.1. Introduction 19.2. Historical Market Size (US$ Billion) Analysis By Market Taxonomy, 2017 to 2022 19.3. Market Size (US$ Billion) Forecast By Market Taxonomy, 2023 to 2033 19.3.1. By Country 19.3.1.1. Australia 19.3.1.2. New Zealand 19.3.2. By Product 19.3.3. By Type 19.3.4. By Dosage Forms 19.3.5. By Route of Administration 19.3.6. By Indication 19.3.7. By Distribution Channel 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product 19.4.3. By Type 19.4.4. By Dosage Forms 19.4.5. By Route of Administration 19.4.6. By Indication 19.4.7. By Distribution Channel 19.5. Country Level Analysis & Forecast 19.5.1. Australia Market Analysis 19.5.1.1. Introduction 19.5.1.2. Market Analysis and Forecast by Market Taxonomy 19.5.1.2.1. By Product 19.5.1.2.2. By Type 19.5.1.2.3. By Dosage Forms 19.5.1.2.4. By Route of Administration 19.5.1.2.5. By Indication 19.5.1.2.6. By Distribution Channel 19.5.2. New Zealand Market Analysis 19.5.2.1. Introduction 19.5.2.2. Market Analysis and Forecast by Market Taxonomy 19.5.2.2.1. By Product 19.5.2.2.2. By Type 19.5.2.2.3. By Dosage Forms 19.5.2.2.4. By Route of Administration 19.5.2.2.5. By Indication 19.5.2.2.6. By Distribution Channel 19.6. Market Trends 19.7. Key Market Participants - Intensity Mapping 19.8. Drivers and Restraints - Impact Analysis 20. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 20.1. Introduction 20.2. Historical Market Size (US$ Billion) Analysis By Market Taxonomy, 2017 to 2022 20.3. Market Size (US$ Billion) Forecast By Market Taxonomy, 2023 to 2033 20.3.1. By Country 20.3.1.1. GCC Countries 20.3.1.2. Türkiye 20.3.1.3. Northern Africa 20.3.1.4. South Africa 20.3.1.5. Rest of Middle East and Africa 20.3.2. By Product 20.3.3. By Type 20.3.4. By Dosage Forms 20.3.5. By Route of Administration 20.3.6. By Indication 20.3.7. By Distribution Channel 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Product 20.4.3. By Type 20.4.4. By Dosage Forms 20.4.5. By Route of Administration 20.4.6. By Indication 20.4.7. By Distribution Channel 20.5. Country Level Analysis & Forecast 20.5.1. GCC Countries Market Analysis 20.5.1.1. Introduction 20.5.1.2. Market Analysis and Forecast by Market Taxonomy 20.5.1.2.1. By Product Type 20.5.1.2.2. By Route of Administration 20.5.1.2.3. By Indication 20.5.1.2.4. By Distribution Channel 20.5.2. Türkiye Market Analysis 20.5.2.1. Introduction 20.5.2.2. Market Analysis and Forecast by Market Taxonomy 20.5.2.2.1. By Product 20.5.2.2.2. By Type 20.5.2.2.3. By Dosage Forms 20.5.2.2.4. By Route of Administration 20.5.2.2.5. By Indication 20.5.2.2.6. By Distribution Channel 20.5.3. Northern Africa Market Analysis 20.5.3.1. Introduction 20.5.3.2. Market Analysis and Forecast by Market Taxonomy 20.5.3.2.1. By Product 20.5.3.2.2. By Type 20.5.3.2.3. By Dosage Forms 20.5.3.2.4. By Route of Administration 20.5.3.2.5. By Indication 20.5.3.2.6. By Distribution Channel 20.5.4. South Africa Market Analysis 20.5.4.1. Introduction 20.5.4.2. Market Analysis and Forecast by Market Taxonomy 20.5.4.2.1. By Product 20.5.4.2.2. By Type 20.5.4.2.3. By Dosage Forms 20.5.4.2.4. By Route of Administration 20.5.4.2.5. By Indication 20.5.4.2.6. By Distribution Channel 20.6. Market Trends 20.7. Key Market Participants - Intensity Mapping 20.8. Drivers and Restraints - Impact Analysis 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Share Analysis of Top Players 21.3. Market Presence Analysis 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep Dive 22.3.1. GlaxoSmithKline PLC. 22.3.1.1. Overview 22.3.1.2. Product Portfolio 22.3.1.3. Profitability by Market Segments (Product/Region) 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.2. Sanofi Consumer Healthcare 22.3.3. Himalaya Wellness Company 22.3.4. Sun Pharmaceutical Industries, Inc. 22.3.5. Bayer AG 22.3.6. Novartis AG 22.3.7. Cadila Pharmaceuticals 22.3.8. Bausch Health Companies Inc. 22.3.9. Alcon Vision LLC. 22.3.10. Merck & Co. 22.3.11. Dr. Reddy’s Laboratories, Ltd. 22.3.12. Viatris Inc. 22.3.13. Somerset Pharma, LLC 22.3.14. F. Hoffmann- La Roche Ltd. 22.3.15. Akorn Operating Company LLC 22.3.16. Teva Pharmaceutical Industries Ltd. 22.3.17. Speer laboratories 22.3.18. Glenmark Pharmaceuticals Limited 22.3.19. TerSera Therapeutics LLC 22.3.20. Pfizer Inc. 22.3.21. Johnson & Johnson Consumer Inc. 22.3.22. Pharmaceutical Specialties Inc. 22.3.23. Proctor & Gamble 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports
Antihistamine Market
